These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 17622393)
21. Comparison of the management and in-hospital outcomes of acute coronary syndrome patients in Australia and New Zealand: results from the binational SNAPSHOT acute coronary syndrome 2012 audit. Ellis C; Hammett C; Ranasinghe I; French J; Briffa T; Devlin G; Elliott J; Lefkovitz J; Aliprandi-Costa B; Astley C; Redfern J; Howell T; Carr B; Lintern K; Bloomer S; Farshid A; Matsis P; Hamer A; Williams M; Troughton R; Horsfall M; Hyun K; Gamble G; White H; Brieger D; Chew D; Intern Med J; 2015 May; 45(5):497-509. PubMed ID: 25764311 [TBL] [Abstract][Full Text] [Related]
22. Paying the right price for pharmaceuticals: a case study of why the comparator matters. Spinks JM; Richardson JR Aust Health Rev; 2011 Aug; 35(3):267-72. PubMed ID: 21871185 [TBL] [Abstract][Full Text] [Related]
23. Painting a picture of trans-Tasman mortality. Campbell M; Bowie C; Kingham S; McCarthy JP Public Health; 2015 Apr; 129(4):396-402. PubMed ID: 25746155 [TBL] [Abstract][Full Text] [Related]
24. The Canadian Cardiovascular Society and reference-based drug pricing. Olley PM; McLaughlin PR Can J Cardiol; 1998 May; 14(5):669-70. PubMed ID: 9627521 [No Abstract] [Full Text] [Related]
25. Comparison of work related fatal injuries in the United States, Australia, and New Zealand: method and overall findings. Feyer AM; Williamson AM; Stout N; Driscoll T; Usher H; Langley JD Inj Prev; 2001 Mar; 7(1):22-8. PubMed ID: 11289530 [TBL] [Abstract][Full Text] [Related]
26. Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. Parkinson B; Sermet C; Clement F; Crausaz S; Godman B; Garner S; Choudhury M; Pearson SA; Viney R; Lopert R; Elshaug AG Pharmacoeconomics; 2015 Sep; 33(9):905-24. PubMed ID: 26048353 [TBL] [Abstract][Full Text] [Related]
27. Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price. Roughead EE; Kim DS; Ong B; Kemp-Casey A WHO South East Asia J Public Health; 2018 Sep; 7(2):99-106. PubMed ID: 30136668 [TBL] [Abstract][Full Text] [Related]
28. Treatment limitations at admission to intensive care units in Australia and New Zealand: prevalence, outcomes, and resource use*. Godfrey G; Pilcher D; Hilton A; Bailey M; Hodgson CL; Bellomo R Crit Care Med; 2012 Jul; 40(7):2082-9. PubMed ID: 22584761 [TBL] [Abstract][Full Text] [Related]
29. International differences in evolution of early discharge after acute myocardial infarction. Kaul P; Newby LK; Fu Y; Mark DB; Califf RM; Topol EJ; Aylward P; Granger CB; Van de Werf F; Armstrong PW Lancet; 2004 Feb; 363(9408):511-7. PubMed ID: 14975612 [TBL] [Abstract][Full Text] [Related]
30. Systematic review of rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand. McDougall C; Hurd K; Barnabe C Semin Arthritis Rheum; 2017 Apr; 46(5):675-686. PubMed ID: 27914688 [TBL] [Abstract][Full Text] [Related]
31. International variation in and factors associated with hospital readmission after myocardial infarction. Kociol RD; Lopes RD; Clare R; Thomas L; Mehta RH; Kaul P; Pieper KS; Hochman JS; Weaver WD; Armstrong PW; Granger CB; Patel MR JAMA; 2012 Jan; 307(1):66-74. PubMed ID: 22215167 [TBL] [Abstract][Full Text] [Related]
32. Comparative mental health policy: are there lessons to be learned? Lurie S Int Rev Psychiatry; 2005 Apr; 17(2):97-101. PubMed ID: 16194778 [TBL] [Abstract][Full Text] [Related]
33. Descriptive, cross-country analysis of the nurse practitioner workforce in six countries: size, growth, physician substitution potential. Maier CB; Barnes H; Aiken LH; Busse R BMJ Open; 2016 Sep; 6(9):e011901. PubMed ID: 27601498 [TBL] [Abstract][Full Text] [Related]
34. Exploring a Hidden Epidemic: Drowning Among Adults Aged 65 Years and Older. Clemens T; Peden AE; Franklin RC J Aging Health; 2021 Dec; 33(10):828-837. PubMed ID: 33939560 [No Abstract] [Full Text] [Related]
35. Primary care and health reform in New Zealand. Grant CC; Forrest CB; Starfield B N Z Med J; 1997 Feb; 110(1037):35-9. PubMed ID: 9066566 [TBL] [Abstract][Full Text] [Related]
36. Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom. Morgan SG; McMahon M; Mitton C; Roughead E; Kirk R; Kanavos P; Menon D Health Aff (Millwood); 2006; 25(2):337-47. PubMed ID: 16522575 [TBL] [Abstract][Full Text] [Related]
37. Subarachnoid Hemorrhage Patients Admitted to Intensive Care in Australia and New Zealand: A Multicenter Cohort Analysis of In-Hospital Mortality Over 15 Years. Udy AA; Vladic C; Saxby ER; Cohen J; Delaney A; Flower O; Anstey M; Bellomo R; Cooper DJ; Pilcher DV; Crit Care Med; 2017 Feb; 45(2):e138-e145. PubMed ID: 27749342 [TBL] [Abstract][Full Text] [Related]
38. Chagas disease in Australia and New Zealand: risks and needs for public health interventions. Jackson Y; Pinto A; Pett S Trop Med Int Health; 2014 Feb; 19(2):212-8. PubMed ID: 24299280 [TBL] [Abstract][Full Text] [Related]
39. Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review. Babar ZU; Gammie T; Seyfoddin A; Hasan SS; Curley LE Res Social Adm Pharm; 2019 Mar; 15(3):231-243. PubMed ID: 29678413 [TBL] [Abstract][Full Text] [Related]
40. A bibliometric review of drug and alcohol research focused on Indigenous peoples of Australia, New Zealand, Canada and the United States. Clifford A; Shakeshaft A Drug Alcohol Rev; 2017 Jul; 36(4):509-522. PubMed ID: 28334457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]